Menu Back to Marketing-Pharmaceuticals-2015-Drug-Device-Marketing-in-an-Evolving-Environment


Although Washington DC is experiencing inclement weather, the Marketing Pharmaceuticals Conference will proceed as scheduled.  We look forward to seeing everyone in DC. 

Tutorial:  February 17
OPDP/APLB and Compliance 101: A Primer

Conference: February 18-19 


This conference will explore drug and device marketing in an evolving environment while serving as a vital forum for all stakeholders involved with the marketing, advertising, and promotion of a wide range of health care products.  The importance of understanding the complex regulations regarding the marketing of pharmaceuticals, veterinary products, biologics, and medical devices has never been higher.  Recent actions by the FDA in response to rapidly expanding technologies have left organizations behind in their compliance efforts. 

To understand these recent enforcement actions, this conference features sessions led by those heavily involved in the regulation of marketing pharmaceuticals.  These sessions will offer insight into avoiding regulatory pitfalls while serving as a neutral forum to ask questions.   

Who should attend?

Professionals in pharmaceutical, biologics, veterinary drug and medical device companies involved in:

  • Compliance 
  • Corporate Communications
  • Legal 
  • Marketing 
  • Medical Information and Affairs 
  • Public Relations
  • Regulatory Affairs 
  • Senior Management

Learning objectives

At the conclusion of this meeting, participants should be able to:

  • Identify the trends reflected in the latest enforcement actions and policies issued by the FDA
  • Compare how other companies are complying with government regulatory requirements
  • Discuss best review and approval practices with industry colleagues
  • Assess novel promotional tactics trending in the pharmaceutical industry
  • Identify emerging issues in the oversight of marketing materials

Program Committee

  • Thomas W. Abrams, MBA
    Thomas W. Abrams, MBA Director, Office of Prescription Drug Promotion, OMP, CDER
    FDA, United States
  • Glenn N. Byrd, MBA, RAC
    Glenn N. Byrd, MBA, RAC Senior Director, Specialty Care Promotional Regulatory Affairs
    AstraZeneca, United States
  • Dale  Cooke, MA
    Dale Cooke, MA President
    PhillyCooke Consulting , United States
  • Mark  Gaydos
    Mark Gaydos VP, NA General Medicines & Established Products US Adv & Promo, Global Reg Aff
    Sanofi, United States
  • Lynette  Hopkinson
    Lynette Hopkinson Vice President, Commercial Regulatory Affairs, Global Regulatory Affairs
    Vertex Pharmaceuticals Incorporated, United States
  • John T. Murray
    John T. Murray President
    Grayscale Compliance LLC, United States
  • Wayne L. Pines
    Wayne L. Pines President, Regulatory Services and Healthcare
    APCO Worldwide Inc., United States
  • Lucy  Rose, MBA
    Lucy Rose, MBA President
    Lucy Rose and Associates, LLC, United States
  • Kristina  Vlaovic, MPH
    Kristina Vlaovic, MPH Vice President, Regulatory, Safety and Pharmacovigilance
    HALOZYME Inc., United States
Load More

Contact us

Printable Registration Form

Registration Questions
Toll Free 1.888.257.6457
Phone +1.215.442.6100
Fax +1.215.442.6199
Monday-Friday 8:30AM-8:00PM ET

Agenda Details
Meredith Kaganovskiy, Content Lead
Phone +1.215.442.6117
Fax +1.215.442.6199

Event Logistics
Stephanie Ritter, Event Planner
Phone +1.215.442. 6149
Fax +1.215.442.6199

Exhibit Details
Jessica Culp, Exhibit & Event Logistics Associate 
Phone +1.215.442. 6132
Fax +1.215.442.6199 

Digital Learning Catalog

eLearning Catalog Cover